These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G. J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [Abstract] [Full Text] [Related]
4. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome. Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK. Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146 [Abstract] [Full Text] [Related]
6. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. Agaimy A, Terracciano LM, Dirnhofer S, Tornillo L, Foerster A, Hartmann A, Bihl MP. J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230 [Abstract] [Full Text] [Related]
10. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE, Kim MA, Lee HS, Lee BL, Kim WH. J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [Abstract] [Full Text] [Related]
11. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M, Wasag B, Stul M, De Wever I, Van Oosterom A, Hagemeijer A, Sciot R. J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [Abstract] [Full Text] [Related]
17. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL, Gouveia A, Capelinha AF, de la Cruz D, Silva P, Reis RM, Pimenta A, Lopes JM. J Clin Pathol; 2008 Feb 01; 61(2):203-8. PubMed ID: 17827398 [Abstract] [Full Text] [Related]
18. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors]. Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF. Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 01; 11(4):371-5. PubMed ID: 18636362 [Abstract] [Full Text] [Related]
19. Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile. Blandamura S, Alessandrini L, Bertorelle R, Simonato F, Guzzardo V, Valentini E, Angriman I, Fassina A. Pathol Res Pract; 2014 Jun 01; 210(6):392-6. PubMed ID: 24674454 [Abstract] [Full Text] [Related]
20. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Dei Tos AP. Am J Surg Pathol; 2010 Oct 01; 34(10):1480-91. PubMed ID: 20861712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]